Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
Nature Communications
|
August 15, 2025
Efficient fibre-pigtailed source of indistinguishable single photons
Nico Margaria, Florian Pastier, Thinhinane Bennour, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 9, 2025
Assessment of bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone acetate plus prednisone in the PEACE-1 phase 3 trial
Guilhem Roubaud, Marie Kostine, Raymond S McDermott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2018
Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial
Alice Bernard-Tessier, Emmanuelle Jeannot, David Guenat, et al.
Current Oncology Reports
|
July 27, 2024
Exploring the Role of Target Expression in Treatment Efficacy of Antibody-Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive Review
Laurent Mathiot, Capucine Baldini, Octave Letissier, et al.
JCO Precision Oncology
|
August 7, 2025
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations
Mihaela Aldea, Emeline Orillard, Alice Bernard-Tessier, et al.
BMJ Supportive & Palliative Care
|
August 30, 2022
PALLIA 10 score in phase I cancer studies
Kaïssa Ouali, Christine Mateus, Arianne Laparra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2025
Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study
Mark N Stein, Armelle Vinceneux, Debbie Robbrecht, et al.
BMJ Open
|
September 22, 2025
Randomised controlled study investigating standard dose continuous renal replacement therapy (CRRT) versus low-dose CRRT in critically ill patients with acute kidney injury (AKI): study protocol for a prospective, randomised, controlled, international, multicentre trial (the 'Ketzerei' trial)
Christian Strauß, Mahan Sadjadi, Thilo von Groote, et al.
European Urology Oncology
|
April 25, 2024
Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study
Ronan Flippot, Tugce Telli, Maud Velev, et al.
European Urology Oncology
|
March 4, 2024
Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer
Ludovic Bigot, Jonathan Sabio, Loic Poiraudeau, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
Nature Communications
|
August 15, 2025
Efficient fibre-pigtailed source of indistinguishable single photons
Nico Margaria, Florian Pastier, Thinhinane Bennour, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 9, 2025
Assessment of bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone acetate plus prednisone in the PEACE-1 phase 3 trial
Guilhem Roubaud, Marie Kostine, Raymond S McDermott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2018
Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial
Alice Bernard-Tessier, Emmanuelle Jeannot, David Guenat, et al.
Current Oncology Reports
|
July 27, 2024
Exploring the Role of Target Expression in Treatment Efficacy of Antibody-Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive Review
Laurent Mathiot, Capucine Baldini, Octave Letissier, et al.
JCO Precision Oncology
|
August 7, 2025
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations
Mihaela Aldea, Emeline Orillard, Alice Bernard-Tessier, et al.
BMJ Supportive & Palliative Care
|
August 30, 2022
PALLIA 10 score in phase I cancer studies
Kaïssa Ouali, Christine Mateus, Arianne Laparra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2025
Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study
Mark N Stein, Armelle Vinceneux, Debbie Robbrecht, et al.
BMJ Open
|
September 22, 2025
Randomised controlled study investigating standard dose continuous renal replacement therapy (CRRT) versus low-dose CRRT in critically ill patients with acute kidney injury (AKI): study protocol for a prospective, randomised, controlled, international, multicentre trial (the 'Ketzerei' trial)
Christian Strauß, Mahan Sadjadi, Thilo von Groote, et al.
European Urology Oncology
|
April 25, 2024
Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study
Ronan Flippot, Tugce Telli, Maud Velev, et al.
European Urology Oncology
|
March 4, 2024
Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer
Ludovic Bigot, Jonathan Sabio, Loic Poiraudeau, et al.
Page
of 6